相关实验视频
Updated: Sep 16, 2025
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
10.7K
利蒙在新生体和非新生体疾病中的应用
Katarzyna Rakoczy1,2, Natalia Szymańska1,2, Jakub Stecko1,2
1Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
International journal of molecular sciences
|July 12, 2025
概括
的植物化合物D-limonene显示出广泛的健康益处,包括抗氧化和抗癌作用. 进一步的研究支持其在治疗各种疾病的潜在用途,由于其低毒性.
科学领域:
- 药理学和植物治疗.
- 自然产品 化学 化学
背景情况:
- 植物为了生存而产生各种各样的二次代谢物.
- 类单烯的D-烯表现出显著的药理活性.
研究的目的:
- 审查D-烯的生物多样性和分子机制.
- 探索其在各种疾病中的治疗潜力,包括癌症,糖尿病和神经退行.
主要方法:
- 关于d-limonene的临床前和临床早期研究的文献综合.
- 对分子机制的分析,包括抗氧化,抗炎和代谢作用.
主要成果:
- D-氨酸显示出抗氧化,抗炎,抗瘤,抗糖尿病,神经保护和胃保护性质.
- 机制包括活性氧物种缓解,亡诱导,代谢重塑和神经递质调节.
- 在乳腺和肝癌治疗和改善糖尿病和神经退行症的特征中新兴的作用.
结论:
- D-利蒙具有低毒性和高生物可用性,支持其在植物治疗中的使用.
- 继续调查其对瘤和非瘤疾病的翻译潜力是有必要的.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K